BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 27268220)

  • 1. A preoperative risk-scoring system to predict lymph node metastasis in endometrial cancer and stratify patients for lymphadenectomy.
    Imai K; Kato H; Katayama K; Nakanishi K; Kawano A; Iura A; Konnai K; Onose R; Hirahara F; Miyagi E
    Gynecol Oncol; 2016 Aug; 142(2):273-7. PubMed ID: 27268220
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A validation study of a scoring system to estimate the risk of lymph node metastasis for patients with endometrial cancer for tailoring the indication of lymphadenectomy.
    Todo Y; Okamoto K; Hayashi M; Minobe S; Nomura E; Hareyama H; Takeda M; Ebina Y; Watari H; Sakuragi N
    Gynecol Oncol; 2007 Mar; 104(3):623-8. PubMed ID: 17097721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive Value of Kanagawa Cancer Center Scoring System for Lymph Node Metastasis and Need for Lymphadenectomy in Patients With Endometrial Cancer: A Validation Study.
    Momtahan M; Hosseini M; Robati M; Najib F
    Int J Gynecol Cancer; 2018 Sep; 28(7):1290-1296. PubMed ID: 29994911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of lymph node metastasis based on myometrial invasion and tumor grade in endometrioid uterine cancers: a multicenter, retrospective Korean study.
    Lee KB; Ki KD; Lee JM; Lee JK; Kim JW; Cho CH; Kim SM; Park SY; Jeong DH; Kim KT
    Ann Surg Oncol; 2009 Oct; 16(10):2882-7. PubMed ID: 19484311
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lymphadenectomy can be omitted for low-risk endometrial cancer based on preoperative assessments.
    Mitamura T; Watari H; Todo Y; Kato T; Konno Y; Hosaka M; Sakuragi N
    J Gynecol Oncol; 2014 Oct; 25(4):301-5. PubMed ID: 25142623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphovascular space invasion and positive pelvic lymph nodes are independent risk factors for para-aortic nodal metastasis in endometrioid endometrial cancer.
    Solmaz U; Mat E; Dereli ML; Turan V; Tosun G; Dogan A; Sanci M; Ozdemir IA; Pala EE
    Eur J Obstet Gynecol Reprod Biol; 2015 Mar; 186():63-7. PubMed ID: 25638600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymph Node Metastasis in Patients With Endometrioid Endometrial Cancer: Overtreatment Is the Main Issue.
    Karalok A; Turan T; Basaran D; Turkmen O; Comert Kimyon G; Tulunay G; Tasci T
    Int J Gynecol Cancer; 2017 May; 27(4):748-753. PubMed ID: 28301338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment and evaluation of a risk-scoring system for lymph node metastasis in early-stage endometrial carcinoma: Achieving preoperative risk stratification.
    Zhang Y; Zhao W; Chen Z; Zhao X; Ren P; Zhu M
    J Obstet Gynaecol Res; 2020 Nov; 46(11):2305-2313. PubMed ID: 32844525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for pelvic lymph node metastasis in endometrial cancer.
    Li Y; Cong P; Wang P; Peng C; Liu M; Sun G
    Arch Gynecol Obstet; 2019 Oct; 300(4):1007-1013. PubMed ID: 31435773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A patient group at negligible risk of para-aortic lymph node metastasis in endometrial cancer.
    Todo Y; Okamoto K; Takeshita S; Sudo S; Kato H
    Gynecol Oncol; 2016 Apr; 141(1):155-9. PubMed ID: 26825615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymph node metastasis and pattern of recurrence in clinically early stage endometrial cancer with positive lymphovascular space invasion.
    Mahdi H; Jernigan A; Nutter B; Michener C; Rose PG
    J Gynecol Oncol; 2015 Jul; 26(3):208-13. PubMed ID: 25686395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prediction of para-aortic spread by gross pelvic lymph node findings in patients with endometrial carcinoma.
    Luomaranta A; Lohi J; Bützow R; Leminen A; Loukovaara M
    Int J Gynecol Cancer; 2014 May; 24(4):697-702. PubMed ID: 24662132
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of preoperative criteria used to predict lymph node metastasis in endometrial cancer.
    Han SS; Lee SH; Kim DH; Kim JW; Park NH; Kang SB; Song YS
    Acta Obstet Gynecol Scand; 2010; 89(2):168-74. PubMed ID: 19916890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nodal infiltration in endometrial cancer: a prediction model using best subset regression.
    Matsumoto YK; Himoto Y; Nishio M; Kikkawa N; Otani S; Ito K; Yamanoi K; Kato T; Fujimoto K; Kurata Y; Moribata Y; Yoshida H; Minamiguchi S; Mandai M; Kido A; Nakamoto Y
    Eur Radiol; 2024 May; 34(5):3375-3384. PubMed ID: 37882835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nomogram with potential clinical use to predict lymph node metastasis in endometrial cancer patients diagnosed incidentally by postoperative pathological assessment.
    Taşkın S; Şükür YE; Varlı B; Koyuncu K; Seval MM; Ateş C; Yüksel S; Güngör M; Ortaç F
    Arch Gynecol Obstet; 2017 Oct; 296(4):803-809. PubMed ID: 28762064
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical significance of tumor volume in endometrial cancer: a Japan-Korea cooperative study.
    Todo Y; Choi HJ; Kang S; Kim JW; Nam JH; Watari H; Tamakoshi A; Sakuragi N
    Gynecol Oncol; 2013 Nov; 131(2):294-8. PubMed ID: 23954595
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A preoperative and intraoperative scoring system to predict nodal metastasis in endometrial cancer.
    Teixeira AM; Ribeiro R; Schmeler KM; Herzog TJ; Nicolau SM; Marques RM
    Int J Gynaecol Obstet; 2017 Apr; 137(1):78-85. PubMed ID: 28093726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distribution of lymph node metastasis sites in endometrial cancer undergoing systematic pelvic and para-aortic lymphadenectomy: a proposal of optimal lymphadenectomy for future clinical trials.
    Odagiri T; Watari H; Kato T; Mitamura T; Hosaka M; Sudo S; Takeda M; Kobayashi N; Dong P; Todo Y; Kudo M; Sakuragi N
    Ann Surg Oncol; 2014 Aug; 21(8):2755-61. PubMed ID: 24705578
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphadenectomy should be performed up to the renal vein in patients with intermediate-high risk endometrial cancer.
    Alay I; Turan T; Ureyen I; Karalok A; Tasci T; Ozfuttu A; Kose MF; Tulunay G
    Pathol Oncol Res; 2015 Jul; 21(3):803-10. PubMed ID: 25564000
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of gross myometrial invasion with endometrial cancer.
    Larson DM; Connor GP; Broste SK; Krawisz BR; Johnson KK
    Obstet Gynecol; 1996 Sep; 88(3):394-8. PubMed ID: 8752246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.